Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Orr

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cancer Medicine|August 20, 2020
Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registry dataShalkar Adambekov, Samia Lopa, Robert P Edwards, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 2025
The protective role of γδ T cells in endometrial cancerDavid P Mysona, Akash Shah, Natalia Jaeger, et al.
Frontiers in Psychiatry|April 11, 2025
A pilot study of an online group-based Internal Family Systems intervention for comorbid posttraumatic stress disorder and substance useDilara Ally, Laure Tobiasz-Veltz, Kevin Tu, et al.
Journal of Natural Products|January 31, 2006
Isolation and structural modification of 7-deoxynarciclasine and 7-deoxy-trans-dihydronarciclasineGeorge R Pettit, Stephen A Eastham, Noeleen Melody, et al.
JNCI Cancer Spectrum|January 25, 2026
The cervical cancer divide: State variation in incidence, mortality, and progress toward elimination in the USTrisha L Amboree, Poria Dorali, Haluk Damgacioglu, et al.
Cancer Research|June 2, 2018
Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor MicroenvironmentMarie-Nicole Theodoraki, Saigopalakrishna Yerneni, Saumendra N Sarkar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 ImmunityBrian Orr, Haider Mahdi, Yusi Fang, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|September 9, 2020
Circulating CD14<sup>+</sup> HLA-DR<sup>lo/-</sup> monocytic cells as a biomarker for epithelial ovarian cancer progressionAshley E Stenzel, Scott I Abrams, Janine M Joseph, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2024
Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892)Sarah E Taylor, Sarah Behr, Kristine L Cooper, et al.
Science Translational Medicine|December 8, 2021
Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancerChristopher A Chuckran, Anthony R Cillo, Jessica Moskovitz, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Medicine|August 20, 2020
Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registry dataShalkar Adambekov, Samia Lopa, Robert P Edwards, et al.
Cancer Immunology, Immunotherapy : CII|September 29, 2025
The protective role of γδ T cells in endometrial cancerDavid P Mysona, Akash Shah, Natalia Jaeger, et al.
Frontiers in Psychiatry|April 11, 2025
A pilot study of an online group-based Internal Family Systems intervention for comorbid posttraumatic stress disorder and substance useDilara Ally, Laure Tobiasz-Veltz, Kevin Tu, et al.
Journal of Natural Products|January 31, 2006
Isolation and structural modification of 7-deoxynarciclasine and 7-deoxy-trans-dihydronarciclasineGeorge R Pettit, Stephen A Eastham, Noeleen Melody, et al.
JNCI Cancer Spectrum|January 25, 2026
The cervical cancer divide: State variation in incidence, mortality, and progress toward elimination in the USTrisha L Amboree, Poria Dorali, Haluk Damgacioglu, et al.
Cancer Research|June 2, 2018
Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor MicroenvironmentMarie-Nicole Theodoraki, Saigopalakrishna Yerneni, Saumendra N Sarkar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2022
Phase I Trial Combining Chemokine-Targeting with Loco-Regional Chemoimmunotherapy for Recurrent, Platinum-Sensitive Ovarian Cancer Shows Induction of CXCR3 Ligands and Markers of Type 1 ImmunityBrian Orr, Haider Mahdi, Yusi Fang, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|September 9, 2020
Circulating CD14<sup>+</sup> HLA-DR<sup>lo/-</sup> monocytic cells as a biomarker for epithelial ovarian cancer progressionAshley E Stenzel, Scott I Abrams, Janine M Joseph, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2024
Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892)Sarah E Taylor, Sarah Behr, Kristine L Cooper, et al.
Science Translational Medicine|December 8, 2021
Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancerChristopher A Chuckran, Anthony R Cillo, Jessica Moskovitz, et al.
Pageof 2